BRCA1 and breast carcinoma: For instance, an eight gene promoter hypermethylation panel (APC, BRCA1, BIN1, CST6, GSTP1, P16, P21, and TIMP3) had a reported sensitivity of 90% for identifying breast cancer patients [74,113].